{"created":"2023-05-15T14:36:08.001914+00:00","id":46511,"links":{},"metadata":{"_buckets":{"deposit":"143d4afa-3648-4a6e-baf7-f5ce761ed63f"},"_deposit":{"created_by":1,"id":"46511","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"46511"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00046511","sets":["1"]},"author_link":["463502","463503","463504","463499","463498","463496","463500","463497","463501","463506","463505"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-09","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9","bibliographicPageEnd":"4018","bibliographicPageStart":"4013","bibliographicVolumeNumber":"32","bibliographic_titles":[{"bibliographic_title":"Anticancer Research"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Aim: To evaluate the value of hyperfractionated radiotherapy with concurrent use of low-dose docetaxel in locally-advanced head and neck squamous cell cancer (HNSCC). Patients and Methods: Patients eligible for this study had confirmed diagnosis of HNSCC stages II (>10 cm3) to IVB. Radiotherapy was delivered twice daily at 1.2 Gy/fraction to a total dose of 72.0 Gy. Docetaxel (10 mg/m2) was administered weekly during radiotherapy. Results: From March 2003 to October 2008, 70 patients were treated. Primary sites included the oropharynx (n=25), hypopharynx (n=24), larynx (n=18), and other sites (n=3). Major grade 3 acute toxicities included mucositis (n=43) and treatment-related pain (n=20). The median follow-up period for surviving patients was 43 months. The 5-year local control rate and overall survival rate were 62.6% and 61.6%, respectively. Conclusion: This modality is a valuable treatment option for the management of locally-advanced HNSCC.","subitem_description_type":"Abstract"}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0250-7005","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Karasawa, Kumiko"}],"nameIdentifiers":[{"nameIdentifier":"463496","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Matsumoto, Fumihiko"}],"nameIdentifiers":[{"nameIdentifier":"463497","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ito, Shin"}],"nameIdentifiers":[{"nameIdentifier":"463498","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Oba, Shinichi"}],"nameIdentifiers":[{"nameIdentifier":"463499","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Furuya, Tomohisa"}],"nameIdentifiers":[{"nameIdentifier":"463500","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hirowatari, Hisako"}],"nameIdentifiers":[{"nameIdentifier":"463501","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Izawa, Hiromi"}],"nameIdentifiers":[{"nameIdentifier":"463502","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ito, Kana"}],"nameIdentifiers":[{"nameIdentifier":"463503","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sasai, Keisuke"}],"nameIdentifiers":[{"nameIdentifier":"463504","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"唐澤 久美子","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"463505","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"笹井 啓資","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"463506","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-03-28"},"publish_date":"2013-03-28","publish_status":"0","recid":"46511","relation_version_is_last":true,"title":["Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:50:53.946526+00:00"}